AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-15.94%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$58.5M
AUM Growth
+$58.5M
(-24%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Akebia Therapeutics
AKBA
$833M
| $18.5M | 31.57% |
16,205,119
| – | – |
|
2
Annexon
ANNX
$226M
| $16.7M | 28.46% |
7,056,024
| – | – |
|
3
American Well
AMWL
$111M
| $12.3M | 20.95% |
10,475,717
| – | – |
|
|
WHWK
4
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $7.89M | 13.49% |
1,630,830
| – | – |
|
5
Assembly Biosciences
ASMB
$190M
| $1.97M | 3.37% |
2,227,500
| – | – |
|
|
RNTX
6
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $1.26M | 2.16% |
830,466
| – | – |
|